What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“CaNCURE has granted me the opportunity to conduct independent cancer research, by providing me with a strong foundational education in nanomedicine as well as exceptionally experienced mentorship.”

Joseph Nneji, Biochemistry, ’16


Trainee Spotlight


Claire Buxton

Molecular Biology, '21

Role of ESRP1/ESRP2 splicing regulators in the development of Triple-Negative Breast Cancer

Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Hannah Curtis

Health Science, '21

The Role of CD8+ and CD4+ in the Tumor Microenvironment (TME) after Controlled Exercise in E0771/M3C Breast Cancer Models

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Tayyaba Hasan, Ph.D.

Professor of Dermatology, HMS

Our group has extensive expertise in the photodynamic therapy of cancer, infections, and infectious disease, as well as targeted drug delivery using site-directed photochemistry. Students will participate in the design and testing of photoactivatable nanoparticles for the treatment of ovarian, prostate, pancreatic, or head and neck cancer.


Kenneth Anderson,

Physician of Oncology ,

Focuses on translational research in multiple myeloma. Students will have the opportunity to characterize factors in the marrow microenvironment which allow tumor cell homing, growth and resistance to apoptosis in the marrow millieu in order to identify and validate next-generation novel small molecule and immune targeted therapies.


Trainee Spotlight


Muskaan Rastogi

Health Science, '21

Monocyte Subtype Determination by Labeling with Feraheme Nanoparticles

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Marina Yamada

Health Science, '21

Triple-targeted Photonanomedicine: A Strategy to Treat Heterogeneous Tumors


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...